CIK 0001642380
- Non-accelerated filer
- Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- Operating
- EIN
- 271041563
- Phone
- +1 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 23 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-12-28 | KINGSLEY ALFRED D Director | Option exercise | +65,271 | $1.34 | $87K | 384,111 |
| 2020-12-28 | KINGSLEY ALFRED D Director | Option exercise · Option to purchase common stock | +65,271 | $1.34 | $87K | 0 |
| 2020-12-23 | KINGSLEY ALFRED D Director | Option exercise | +1,237 | $1.34 | $2K | 319,740 |
| 2020-12-23 | KINGSLEY ALFRED D Director | Sale | −900 | $2.55 | $2K | 318,840 |
| 2020-12-23 | KINGSLEY ALFRED D Director | Option exercise · Option to purchase common stock | +1,237 | $1.34 | $2K | 65,271 |
| 2020-12-22 | KINGSLEY ALFRED D Director | Option exercise | +10,516 | $1.34 | $14K | 326,155 |
| 2020-12-22 | KINGSLEY ALFRED D Director | Sale | −7,652 | 318,503 | ||
| 2020-12-22 | KINGSLEY ALFRED D Director | Option exercise · Option to purchase common stock | +10,516 | $1.34 | $14K | 66,508 |
| 2020-12-21 | KINGSLEY ALFRED D Director | Option exercise | +47,976 | $1.34 | $64K | 350,787 |
| 2020-12-21 | KINGSLEY ALFRED D Director | Sale | −30,000 | 320,787 | ||
| 2020-12-21 | KINGSLEY ALFRED D Director | Sale | −5,148 | $2.54 | $13K | 315,639 |
| 2020-12-21 | KINGSLEY ALFRED D Director | Option exercise · Option to purchase common stock | +47,976 | $1.34 | $64K | 77,024 |
| 2020-12-11 | HESTERBERG LYNDAL K. CSO | Grant or award | +6,603 | 7,477 | ||
| 2020-12-11 | Arno Andrew Director | Grant or award | +9,602 | 112,049 | ||
| 2020-12-11 | Last Andrew J. Director | Grant or award | +16,184 | 23,177 | ||
| 2020-12-11 | Sundar Padmavathi SVP, Marketing & Market Access | Grant or award | +4,177 | 4,177 | ||
| 2020-12-11 | Ross Douglas T. CMO | Grant or award | +5,317 | 5,317 | ||
| 2020-12-11 | Parker Albert P COO | Grant or award | +5,586 | 10,586 | ||
| 2020-12-11 | Redmond Cavan M. Director | Grant or award | +18,416 | 70,863 | ||
| 2020-12-11 | KINGSLEY ALFRED D Director | Grant or award | +5,909 | 302,811 |
Page 15 of 20 · 383 trades